key: cord-0758435-9d08gtui
authors: Akbulut, Ekrem
title: Investigation of changes in protein stability and substrate affinity of 3CL-protease of SARS-CoV-2 caused by mutations
date: 2022-04-29
journal: Genet Mol Biol
DOI: 10.1590/1678-4685-gmb-2021-0404
sha: 5586f825b0804b83ff439779612bf4ad184d183c
doc_id: 758435
cord_uid: 9d08gtui

3CL(pro) of SARS-CoV-2 is one of the enzymes required for the replication process of the virus responsible for the COVID-19 pandemic. In this study, changes in protein stability and substrate affinity caused by mutations were investigated to stir the development of potent inhibitors. Sequence data of samples were obtained from the NCBI Virus database. Mutation analyses were performed with RDP4 and MegaX. 3CL(pro) tertiary models were created using Robetta. Molecular docking for peptidomimetic substrate and inhibitor ligand was done with Autodock v4.2 and Haddock v2.4. Protein stability analysis was performed using mCSM stability and DynaMut2. Twenty-four missense mutations in 3CL(pro) were identified in this study. Changes in the 3CL(pro) structure induced by the mutations Met49Thr, Leu167Ser, and Val202Ala resulted in significant levels of instability (-2.029,-2.612,-2.177 kcal.mol(-1), respectively). The lowest interaction energy for substrate was -58.7 kcal.mol(-1) and -62.6 kcal.mol(-1) in wild-type and mutant, respectively. The lowest docking energy for ligand was -6.19 and -9.52 kcal.mol(-1) for wild-type and mutant, respectively. This study reports for the first time that mutations cause increased substrate affinity of 3CL(pro) from SARS-CoV-2. This research provides important data for the development of potent peptidomimetic inhibitors for the treatment of COVID-19.

The etiologic agent of coronavirus disease 2019 , severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has killed more than 4.97 million people worldwide (Wu et al., 2020; Worldometer, 2021) . SARS-CoV-2 is the third zoonotic coronavirus outbreak after the emergence of SARS-CoV and the Middle East Respiratory Syndrome (MERS-CoV) in the last two decades. SARS-CoV-2 is a positive-sense RNA virus (Drosten et al., 2003; Zaki et al., 2012) . The SARS-CoV-2 genome is noted for its high similarity to SARS-CoV and MERS-CoV (Akbulut, 2020a) . Once the SARS-CoV-2 viral genome has entered the host cell, it is translated to yield two overlapping polyproteins (polyprotein1a and polyprotein1ab) (Zhu et al., 2020) . 3-chymotrypsin-like protease (3CL pro ) and papain-like protease (PL pro ) contribute to the activation of 15 different non-structural proteins (nsp) by processing polyprotein1ab from 14 different points (Gao et al., 2021) . The critical role of 3CL pro , a cysteine protease, in converting polyproteins into individual functional proteins for viral replication, as well as the enzyme's highly conserved substrate selectivity among Coronaviruses, make it an attractive target for inhibitor screening (Su et al., 2020) . The active site of 3CL pro is sandwiched between two β-barrel domains, domain I (residue 10-99) and domain II (residue 100-182). Domain , forms a bundle of alpha-helices and is proposed to regulate dimerization (Douangamath et al., 2020) .

Mutations can trigger changes in protein structure and stability, causing changes in protein functional properties, substrate/ligand affinity, and protein-protein interactions (Manolaridis et al., 2018; Kalathiya et al., 2019; Akbulut, 2021a, b) .

Understanding the molecular-level mechanism of peptide cleavage catalyzed by cysteine proteases after mutations are crucial for designing strong structure-based inhibitors (Mengist et al., 2021) . Here, changes in the structure and functional properties of 3CL pro caused by mutations in the nsp5 of SARS CoV-2 were determined. To aid in the creation of efficient 3CL pro inhibitors, structural alterations in proteins were studied.

Mutation data and protein stability analysis Sequence data of 1,536,489 individuals were searched from the NCBI Virus database for the analysis of 3CL pro mutations of SARS CoV-2. The study included 1,474 complete sequence data from the 2,950 sequence data from the Africa. Reference 3CL pro accesion codes are YP_009725301_1 and NC_045512.2. Protein sequence information was aligned with the MAFFT (v7.487) multiple sequence alignment program FFT-NS-i algorithm (Katoh et al., 2018) . The scoring matrix BLOSUM 80 and 1 PAM/k=2 was chosen for the amino acid sequences and nucleotide, respectively (Mount, 2008a,b) . The gap opening penalty was used as 2.0. The mutated residues were analyzed with RDP4 and MegaX tools (Martin et al., 2015; Kumar et al., 2018) . Analysis of changes in protein stability after the mutation was performed using mCSM stability and DynaMut2 (Pires et al., 2014; Rodrigues et al., 2021) . The results were viewed with the NGL viewer (Rodrigues et al., 2021) .

The homology model of the mutant 3CL pro was created using Rosetta algorithms applying the deep residual neural network approach (Yang et al., 2020) . 7K3T (PDB code) was selected as a template. ProSA was used for the structural quality of 3CL pro models (Wiederstein and Sippl, 2007) . Superimpose and conformational analyses of wild-type and mutant proteins were performed with PyMOL (ver2.4.1). Topological differences were calculated with the i-Tasser TM-Score and root mean square deviation (RMSD) algorithm (Xu and Zhang, 2010) .

The wild-type and mutant of 3CL pro were used as targets, and GC376 alpha-ketoamide analog-VR4 (CID 155804578) was used as an inhibitor ligand for molecular docking using AutoDock 4.2 (Steffen et al., 2010) . Molecular docking was performed with a grid box of 70x74x80 (−11.333, −3.139, 5.833) with a grid spacing of 0.375 Å around the binding pocket. The simulations were performed with the Lamarckian genetic algorithm (LGA) (Morris et al., 1998) . The LGA parameters were 100 runs, 2.7x10 4 generations, and 500 population size. A maximum of 2.5x10 7 energy evaluations was applied for each experiment.

The change in substrate affinity after the mutation was tested with the protein-peptide docking using Haddock v2.4 (Van Zundert et al., 2016) . The active site for the 3CL pro was residues number 41,49,140, 144,145,163,165,166,168,172, and 189 . Octa-peptide -SAVLQ/SGF-was used as a substrate to represent the nsp4/nsp5 cleavage site. The number of structures for rigid-body docking was set to 1000. The number of trials for rigid body minimization was set to 5. The number of structures for semi-flexible refinement was set to 200. Refined with short molecular dynamics in open solvent using water. The clustering method was selected Fraction of Common Contacts (FCC). RMSD cutoff for clustering was set to 0.6 Å. Kyte-Doolittle hydrophobicity scale method was used for solvating. Cutoff distance (proton-acceptor) to define a hydrogen bond was set to 2.5 Å. Cutoff distance (carbon-carbon) to define a hydrophobic contact was set to 3.9 Å. Docking parameters were performed as blind docking with default values. Docking results were visualized with Discovery SV (ver20.1, DDS Biovia).

The results showed that a decrease in protein stability increased substrate and ligand affinity. Twenty-four missense mutations were detected in South African isolates of SARS CoV-2 in this study ( Table 1 ). The protein tertiary structure of the mutant 3CL pro was created with trRosetta, a deep neural network-based modeling algorithm. The Z-score of the homology model of mutant 3CL pro was -7.36. The model was within the NMR quality limits. TM-score was 0.97. RMSD of the common residues was 1.601 Å. RMSD in superposition was 0.93 Å. Two of these mutations were shown to improve the stability of the 3CL pro structure, whereas twenty-two were found to destabilize it. Changes in the 3CL pro structure induced by the mutations Met49Thr, Leu167Ser, and Val202Ala resulted in significant levels of instability (-2.029, -2.612, and -2.177 kcal.mol -1 , respectively) ( Table  1 ). It was observed that the stable structure formed by Met 49 , which is involved in the stabilization of the active site with its strong bond network, in the wild protein with 5 hydrophobic, 7 polar interactions, and 2 hydrogen bonds, weakens in the mutant protein (Figure 1a ,b). After the Met49Thr mutation, the hydrophobic interactions between the catalytic residue His 41 and the Met 49 residue were removed. After the Met165Ile and Leu167Ser mutations of Met 165 and Leu 167 residues, which play an important role in the formation of the substratebinding pocket with their polar, hydrophobic, and Van der Walls interactions, significant weakening occurred in the interaction networks ( Figure 1 ). The stable structure formed by Val 202 in domain III, which is involved in dimerization, with five hydrophobic, three polar, one Van der Walls, and one hydrogen bond interactions were reduced to three polar, one Van der Walls, and one hydrogen bond interactions after mutation (Figure 1g ,h). The Asn238Tyr/Ser mutations increased protein stability in its location.

The results of mutations in molecular interaction were tested with molecular docking. The lowest binding energy for ligand was -6.19 kcal.mol -1 and -9.52 kcal.mol -1 for wildtype and mutant 3CL pro , respectively ( Table 2 ). The minimum inhibitory concentration was 28.54 µM and 0.105 µM for wild-type and mutant 3CL pro , respectively. The wild-type Changes in protein structure induced by mutations resulted in increased interest in substrate affinity. FCC and interface-RMSD (i-RMSD) values indicate that the structure with the lowest energy differs significantly from other clusters and that Cluster-1 for wild-type and Cluster-6 for mutant were the correct binding model. While the lowest substrate interaction energy was -58.7 kcal.mol -1 in wild-type, the interaction was achieved with -62.6 kcal.mol -1 in mutant protein (Figure 3) . Z-scores were -1.8 and -2.0 for wildtype/substrate and mutant/substrate complexes, respectively ( Table 3 ). The interaction with the catalytic residues (His 41 and Cys1 45 ) was stronger in the mutant protein, and the formation of the substrate in the mutant protein binding groove was more successful (Figure 4) . RSA-Residue relative solvent accessibility, nP-non polar, uncP-uncharged polar Akbulut 4 Figure 1 -Surface-stick illustration of changes in protein stability induced by highly destabilizing mutations of 3CL pro of SARS-CoV-2. a) Met49/ wild-type, b) Thr49/mutant, c) Met165/wild-type, d) Ile165/mutant, e) Leu167/ wild-type, f) Ser167/mutant, g) Val202/wild-type, h) Ala202/mutant. Bond legends; red-hydrogen, green-hydrophobic, orange-polar, blue-van der walls, navy blue-carbonyl. DocSc-docking score, Ki e -estimated inhibitory constant, Evdw-van der walls energy, Eelec-electrostatic energy. Table 3 -Docking results of wild and mutant 3CL pro of SARS-CoV-2 with the substrate.

DocSc: docking score, i-RMSD: interface RMSD (from the overall lowest-energy structure), Evdw: Van der Waals energy, Eelec: electrostatic energy, Edesolv: desolvation energy, Eair: restraints violation energy.

SARS-CoV-2 will perhaps be one of the most devastating health problems of this century. Despite the success of vaccine studies to prevent the disease, the high mutation rate of SARS-CoV-2 made the current preventive efforts only partially successful, making the studies on the development of therapeutic drugs even more important. In this context, the most important drug targets are cysteine proteases, which provide the functional structure of the SARS-CoV-2 proteome. Cysteine proteases are attractive targets for covalent inhibitors (Kathman et al., 2014) . In this study, changes in 3CL pro stability and activity caused by mutations in South African isolates were investigated in silico. Mutations can cause changes in the structure and stability of drug target proteins, resulting in changes in substrate and ligand affinity (Akbulut, 2020b; Xavier et al., 2021) . In silico studies have achieved great success in recent years due to their contributions to the design and development of effective drug molecules in a short time, taking these changes into account (Prabhavathi et al., 2020; Das et al., 2021) . In this study, the data obtained showed that the decrease in protein stability due to mutations increased the affinity for the substrate and VR4 ligand, a cysteine protease inhibitor.

SARS-CoV-2 3CL pro has two catalytic residues, His 41 and Cys 145 . The residues 49, 140, 144, 163, 165, 166, 168, 172 and 189 are the main structures in the active site formation. The charge change near the active site can alter the energetic barrier to attaining oxyanion transition states (Simón and Goodman, 2010) . The altered electrical charge and hydrophobic interactions as a result of mutations concentrated around the active site may explain the increased ligand and substrate affinity, and catalytic activity (Table 1 ). In dimerization, Glu 166 gets close to the N-terminus of the protein. This movement contributes to the completion of the active site formation by providing the formation of the substrate specificity pocket and the oxyanion hole (Hilgenfeld, 2014) . Conservation of the conformations of Glu 166 and Phe 140 involved in dimerization may indicate successful dimerization despite increased instability by mutations.

The distance between His41:CE1 and Cys145:SG resulting in 0.1 Å divergence after mutation resulted in a narrowing of approximately 1 degree (0.9°) in the angle between His41:NE2-Cys145:SG and His41:CE1--Cys145:SG ( Figure 5 ). The conformational structure and topology of the substrate-binding groove are one of the most fundamental factors determining the catalytic efficiency of 3CL pro . The changes in the substrate-binding groove and the changing topological structure caused by the mutations detected in South African isolates, most of which concern the active site residues and the surrounding area, may explain the increased activity. This might also explain the exponential increase in the number of instances after new mutations (Deparment Health Republic of South Africa, 2021).

The binding patterns presented in this study revealed a high degree of similarity with the high-resolution crystallographic substrate-binding patterns. (MacDonald et al., 2021) . 3CL pro -substrate interactions contribute to fine-tuned substrate geometry that results in substrate-specific catalytic efficiency (Kneller et al., 2020) . The point of interest here is whether SARS-CoV-2 functional proteins, organized by a mechanism that we can evaluate sequentially depending on the variability in substrate affinity, can act in coordination with increased protease activity. The differential affinity of 3CL pro to nonstructural protein substrates for SARS-CoV-2 supports cleavage of pp1ab by a cascading mechanism. Despite the invariance of P1 (Gln) in substrates, the sequences before and after it are thought to play a role in programming this gradual cleavage by limiting the rate of catalytic activity (Snijder et al., 2016; Gildenhuys, 2020) .

The process of formation of SARS-CoV-2 functional proteins begins with the autocleavage of 3CL pro . Phe305Val mutation detected in the C-terminal autocleavage site (Ser 301 -Gln 306 ) increased unstable structure and motility in the autocleavage region (Table 1) . Whether the Phe305Val mutation results in increased autocleavage activity is a further question to be answered.

The high instability caused by the Met49Thr mutation seen in the substrate-binding site results in increased substrateenzyme interaction due to increased mobility. The S2 subbinding site is formed by the Met 49 and Met 165 residues of 3CL pro . Mutations in Met49Thr and Met165Ile induced alterations in the active site's conformation and topology (Figure 1a,b,c,d) .

Glu 166 is one of the key residues in both dimerization and substrate binding (Świderek and Moliner, 2020; Ullrich et al., 2021) . Unstable mutant neighboring residues (162,164,165,167, 168,169 and 170) , which have a role in substrate localization, may be considered to be involved in the increase in substrate interaction of Glu 166 .

This study was the first to report that mutations cause increased substrate affinity of 3CL pro from SARS-CoV-2.

Although mutations indicate increased substrate affinity and viral activity, the positional accuracy and increased affinity of the inhibitory ligand after mutations in the active site may also lead to increased success of therapeutic drugs. In addition, increased substrate affinity inspires efforts to use peptidomimetics without warheads as inhibitors against 3CL pro of SARS-CoV-2.

Comparative genomic and proteomic analysis of SARS CoV-2 -with potential mutation probabilities and drug targeting

SARS CoV-2 spike glycoprotein mutations and changes in protein structure

Mutations in the SARS CoV-2 spike protein may cause functional changes in the protein quaternary structure

Changes in interaction between accessory protein 8 and IL-17RA in UK isolates caused by mutations in the SARS-CoV-2 open reading frame 8

In silico approach for identification of effective and stable inhibitors for COVID-19 main protease (Mpro) from flavonoid based phytochemical constituents of Calendula officinalis

Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

Crystal structure of SARS-CoV-2 papain-like protease

Expanding our understanding of the role polyprotein conformation plays in the coronavirus life cycle

From SARS to MERS: Crystallographic studies on coronaviral proteases enable antiviral drug design

Structural, functional, and stability change predictions in human telomerase upon specific point mutations

A fragment-based method to discover irreversible covalent inhibitors of cysteine proteases

MAFFT online service: Multiple sequence alignment, interactive sequence choice and visualization

Structural plasticity of SARS-CoV-2 3CL Mpro active site cavity revealed by room temperature X-ray crystallography

MEGA X: Molecular evolutionary genetics analysis across computing platforms

Recognition of divergent viral substrates by the SARS-CoV-2 main protease

Cryo-EM structures of a human ABCG2 mutant trapped in ATP-bound and substrate-bound states

RDP4: Detection and analysis of recombination patterns in virus genomes

Structural basis of potential inhibitors targeting SARS-CoV-2 main protease

Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function

Using BLOSUM in sequence alignments

Using PAM matrices in sequence alignments

mCSM: Predicting the effects of mutations in proteins using graph-based signatures

Exploration and evaluation of bioactive phytocompounds against BRCA proteins by in silico approach

DynaMut2: Assessing changes in stability and flexibility upon single and multiple point missense mutations

Enzyme catalysis by hydrogen bonds: The balance between transition State binding and substrate binding in oxyanion holes

The non-structural proteins directing Coronavirus RNA synthesis and processing

AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility

Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients

Revealing the molecular mechanisms of proteolysis of SARS-CoV-2 Mpro by QM/ MM computational methods

Challenges of short substrate analogues as SARS-CoV-2 main protease inhibitors

The HADDOCK2.2 web server: userfriendly integrative modeling of biomolecular complexes

ProSA-web: Interactive web service for the recognition of errors in three-dimensional structures of proteins

A new coronavirus associated with human respiratory disease in China

ThermoMutDB: A thermodynamic database for missense mutations

How significant is a protein structure similarity with TM-score = 0

Improved protein structure prediction using predicted interresidue orientations

Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia

Identification of SARS-CoV-2 3CL protease inhibitors by a quantitative highthroughput screening

The author declare that there is no conflict of interest that could be perceived as prejudicial to the impartiality of the reported research.

EA conceptualization, methodology, formal analysis, EA visualization, writing, editing.

License information: This is an open-access article distributed under the terms of the Creative Commons Attribution License (type CC-BY), which permits unrestricted use, distribution and reproduction in any medium, provided the original article is properly cited.